Canton Strategic Holdings, Inc.
CNTN · Pharmaceutical Preparations · 69.8M shares · +69%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: -$648K (gross $62K, SBC $710K)
Reference price $3.47 · est. market cap ~$242M — last insider sale, 2026-05-26 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D42Clinical/early-stage biotech — clinical-stage biotech micro-cap, funded.
Strengths
- Liquidity — current ratio 5.3 (62nd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Notable holderHeld by 4 notable fund(s): ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP +1 more (as of 2026-03-31)
- AccumulatingInstitutional holders rose 3→4 QoQ (2025-12-31→2026-03-31)
- New fund positionNotable fund(s) opened this quarter: GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC
- Insider sellingInsider selling — 8 open-market sale(s) by 1 insider(s) (~$343,882, last 6mo) Form 4 ↗
Key metrics
Return on equity
-9.0%
Return on assets
-6.9%
Current ratio
5.3×
Tangible book value
$398M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-26 | Stetz Gary S. | Sell | 12K | $3.47 |
| 2026-05-22 | Stetz Gary S. | Sell | 10K | $3.45 |
| 2026-05-22 | Stetz Gary S. | Sell | 15K | $3.40 |
| 2026-05-22 | Stetz Gary S. | Sell | 15K | $3.41 |
| 2026-05-22 | Stetz Gary S. | Sell | 15K | $3.41 |
| 2026-05-22 | Stetz Gary S. | Sell | 10K | $3.40 |
| 2026-05-22 | Stetz Gary S. | Sell | 13K | $3.44 |
| 2026-05-22 | Stetz Gary S. | Sell | 10K | $3.45 |
| 2025-06-23 | Anderson Kelly | Grant | 6.3K | — |
| 2025-06-20 | Gravitas Capital LP | Buy | 338K | $1.48 |
| 2025-06-20 | Parikh Sanam | Buy | 1.0K | $1.45 |
| 2025-06-20 | Appajosyula Sireesh | Buy | 61K | $1.48 |
| 2025-06-20 | Appajosyula Sireesh | Buy | 690 | $1.42 |
| 2025-05-15 | Parikh Sanam | Buy | 770 | $1.30 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-16 | Reg FDOtherExhibits | filing ↗ |
| 2026-03-31 | OtherExhibits | filing ↗ |
| 2026-03-03 | Material agreementExhibits | filing ↗ |
| 2026-03-03 | OtherExhibits | filing ↗ |
| 2026-02-18 | 5.03Reg FDExhibits | filing ↗ |
| 2026-02-06 | Exec/director changeReg FDOtherExhibits | filing ↗ |
| 2026-02-02 | Shareholder voteOtherExhibits | filing ↗ |
| 2026-01-26 | OtherExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-16 | 2026-06-11 | 0001493152-26-028822 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001493152-26-022629 ↗ |
| 10-K | 2026-03-31 | 2025-12-31 | 0001493152-26-013861 ↗ |
| 8-K | 2026-03-31 | 2026-03-31 | 0001493152-26-013823 ↗ |
| 8-K | 2026-03-03 | 2026-03-03 | 0001493152-26-008716 ↗ |
| 8-K | 2026-03-03 | 2026-03-03 | 0001493152-26-008651 ↗ |
| 8-K | 2026-02-18 | 2026-02-18 | 0001493152-26-007277 ↗ |
| 8-K | 2026-02-06 | 2026-02-05 | 0001493152-26-005453 ↗ |
| 8-K | 2026-02-02 | 2026-01-30 | 0001493152-26-004650 ↗ |
| 8-K | 2026-01-26 | 2026-01-26 | 0001493152-26-003539 ↗ |
| 8-K | 2026-01-22 | 2026-01-20 | 0001493152-26-003242 ↗ |
| 8-K | 2026-01-20 | 2026-01-20 | 0001493152-26-002787 ↗ |